LANDRI Marcellin
| : | - | |
|---|---|---|
| Membre du laboratoire | : | Oui |
| Organisme | : | - |
| Equipes | : | CHOC |
Références (3)
ACL
Landri M, Vasseur M, Monville F, Leca V, Hamdad C, Mercadal M, Vanhille L, Kassambara A, Benzekry S, Ray ML, Roumieux M, Malkoun R, Boyer A, Audigier-Valette C, Martinez S, Pegliasco H, Ray P, Falchero L, Serre A, Cloarec N, Lebas L, Hominal S, Barré P, Zahi S, Frikha A, Bory P, Laborde L, Mazières J, Pérol M, Greillier L, Barlesi F, Fieschi J (2023) 782-C Regulatory T-cell tumor infiltration is associated to better outcome in advanced NSCLC patients under ≥2nd line anti-PD1/L1 monotherapy in the PIONeeR project. J Immunother Cancer 11 | doi: 10.1136/jitc-2023-SITC2023.0782-C